Tigatuzumab (Synonyms:替加组单抗)
目录号 : KM38391 CAS No. : 918127-53-4 纯度 : 98%
Tigatuzumab (CS-1008) 是一种靶向 death receptor 5 (DR5) 的人源 IgG1 单克隆抗体。Tigatuzumab 可诱导癌细胞凋亡,并抑制体内抑制肿瘤生长。Tigatuzumab 可用于癌症研究。
规格 价格 是否有货 数量
1mg
In-stock
5mg 询价 In-stock
10mg 询价 In-stock
50mg 询价 In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer.
分子量
144.64 kDa
CAS号
918127-53-4
中文名称
TIGATUZUMAB ( 替加组单抗 )
运输条件
Shipping with dry ice.
储存方式
Store at -20˚C 
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2